Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction

Regulatory Peptides

Volumn 140, Issue 1-2, 2007, Pages 12-20

  Yao, Yu Yu ^a,b   Yin, Hang ^b   Shen, Bo ^b   Chao, Lee ^b   Chao, Julie ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Inflammation; Kallikrein; Kinin B2 receptor; Myocardial infarction; NF B; Oxidative stress

Indexed keywords

CASPASE 3; CD79B ANTIGEN; GLYCOGEN SYNTHASE KINASE 3BETA; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; TISSUE KALLIKREIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; BRADYKININ; CELL NUCLEUS; CHEMOKINE CCL2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; RATS; RATS, WISTAR; TISSUE KALLIKREINS; VASCULAR CELL ADHESION MOLECULE-1; VENTRICULAR REMODELING;

RATTUS;

EID: 33847033769     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.11.020     Document Type: Article

References (34)

1. Sia Y.T., Parker T.G., Liu P., Tsoporis J.N., and Adam A. Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol 39 (2002) 148-156
2. Krijnen P.A., Meischl C., Hack C.E., Meijer C.J., Visser C.A., Roos D., and Niessen H.W. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 56 (2003) 194-199
3. Duranteau J., Chandel N.S., Kulisz A., Shao Z., and Schumacker P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273 (1998) 11619-11624
4. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 23-38
5. Khaper N., Kaur K., Li T., Farahmand F., and Singal P.K. Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem 251 (2003) 9-15
6. Altavilla D., Deodato B., Campo G.M., Arlotta M., Miano M., Squadrito G., Saitta A., Cucinotta D., Ceccarelli S., Ferlito M., Tringali M., Minutoli L., Caputi A.P., and Squadrito F. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 47 (2000) 515-528
7. Omura T., Yoshiyama M., Kim S., Matsumoto R., Nakamura Y., Izumi Y., Ichijo H., Sudo T., Akioka K., Iwao H., Takeuchi K., and Yoshikawa J. Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression. Arterioscler Thromb Vasc Biol 24 (2004) 270-275
8. Lu L., Chen S.S., Zhang J.Q., Ramires F.J., and Sun Y. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem Biophys Res Commun 321 (2004) 879-885
9. Nolly H.L., Saed G., Scicli G., Carretero O.A., and Scicli A.G. The kallikrein-kinin system in cardiac tissue. Agents Actions Suppl 38 (1992) 62-72
10. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininase. Pharmacol Rev 44 (1992) 1-80
11. Griol-Charhbili V., Messadi-Laribi E., Bascands J.L., Heudes D., Meneton P., Giudicelli J.F., Alhenc-Gelas F., and Richer C. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J 19 (2005) 1172-1174
12. Tschope C., Walther T., Escher F., Spillmann F., Du J., Altmann C., Schimke I., Bader M., Sanchez-Ferrer C.F., Schultheiss H.P., and Noutsias M. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J 19 (2005) 2057-2059
13. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
14. Chao J., and Margolius H.S. Isozymes of rat urinary kallikrein. Biochem Pharmacol 28 (1979) 2071-2079
15. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., and Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214 (1993) 11-16
16. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
17. de Cavanagh E.M., Fraga C.G., Ferder L., and Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol 272 (1997) R514-R518
18. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
19. Yin H., Chao L., and Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem 280 (2005) 8022-8030
20. Bledsoe G., Chao L., and Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 285 (2003) H1479-H1488
21. Zhang H.M., Yuan J., Cheung P., Luo H., Yanagawa B., Chau D., Stephan-Tozy N., Wong B.W., Zhang J., Wilson J.E., McManus B.M., and Yang D. Overexpression of interferon-γ-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/akt pathway and inhibition of viral replication. J Biol Chem 278 (2003) 33011-33019
22. Haq S., Choukroun G., Kang Z.B., Ranu H., Matsui T., Rosenzweig A., Molkentin J.D., Alessandrini A., Woodgett J., Hajjar R., Michael A., and Force T. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 151 (2000) 117-130
23. Li H.J., Yin H., Yao Y.Y., Shen B., Bader M., Chao L., and Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation. Cardiovasc Res 73 (2006) 10.1016/j.cardiores.2006.10.014
24. Xu Z., Park S.S., Mueller R.A., Bagnell R.C., Patterson C., and Boysen P.G. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res 65 (2005) 803-812
25. Fujii H., Ichimori K., Hoshiai K., and Nakazawa H. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem 272 (1997) 32773-32778
26. Colasanti M., and Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21 (2000) 249-252
27. Förstermann U., and Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113 (2006) 1708-1714
28. Yoshiyama M., Omura T., Takeuchi K., Kim S., Shimada K., Yamagishi H., Teragaki M., Akioka K., Iwao H., and Yoshikawa J. Angiotensin blockade inhibits increased JNKs, AP-1 and NF-κB DNA-binding activities in myocardial infarcted rats. J Mol Cell Cardiol 33 (2001) 799-810
29. Zhang G.X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., Nagai Y., Fujisawa Y., Miyatake A., and Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rat. Cardiovasc Res 65 (2005) 230-238
30. Wang J., Xu N., Feng X., Hou N., Zhang J., Cheng X., Chen Y., Zhang Y., and Yang X. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 97 (2005) 821-828
31. Calixto J.B., Carbrini D.A., Ferreira J., and Compos M.M. Kinins in pain and inflammation. Pain 87 (2000) 1-5
32. Tschope C., Heringer-Walther S., and Walther T. Regulation of the kinin receptors after induction of myocardial infarction: a mini-review. Braz J Med Biol Res 33 (2000) 701-708
33. Araujo R.C., Kettritz R., Fichtner I., Paiva A.C., Pesquero J.B., and Bader M. Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol Chem 382 (2001) 91-95
34. Souza D.G., Lomez E.S., Pinho V., Pesquero J.B., Bader M., Pesquero J.L., and Teixeira M.M. Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J Immunol 172 (2004) 2542-2548